Binding of [3H]progesterone to the human progesterone receptor: differences between individual and mixed isoforms
0013.7227/96/$03.00/O
Endocrinology
Copyright
G 1996 by The Endomne
Vol. 137, No 6
Prrnted in U S.A.
Soaety
Binding
of [3H]Progesterone
to the Human
Progesterone
Receptor:
Differences
between
Individual
and Mixed
Isoforms*
P. CARBAJO,
K. CHRISTENSEN,
D. P. EDWARDS,
AND
D. F. SKAFAR
Department
of Physiology,
Wayne State University School of Medicine,
Detroit, Michigan
the Department
of Pathology and Program
in Molecular
Biology, University of Colorado
Sciences Center (K.C., D.P.E.), Denver, Colorado 80262
ABSTRACT
The human
progesterone
receptor
(hPR) exists as two isoforms,
hPR-A and hPR-B,
which differ only in that hPR-A lacks 164 amino
acids present
at the amino-terminus
of hPR-B.
In this study we have
separately
expressed
hPR-A and hPR-B and asked whether
the progesterone-binding
mechanisms
are the same or different
for the two
forms of hPR and for their mixture.
We investigated
1) the cooperativity
of binding
[“HIprogesterone
to the receptor,
as measured
by
the Hill coefficient
(n,);
and 2) the dissociation
rate of [“Hlprogesterone from the receptor.
To compare
the effects of dimerization,
these
ligand-binding
properties
were measured
over a range of receptor
concentrations.
Binding
of [“Hlprogesterone
to hPR-A was positively
cooperative
at all concentrations
used; the limiting
value for the Hill
coefficient
was 1.47 2 0.11 at high receptor
concentrations
(5-19 nM)
and 1.31 + 0.06 at low receptor
concentrations
(l-4
nM). Similarly,
little change was observed
in the dissociation
rate constant
over the
same concentration
range; the values at high and low concentrations
were 4.59 % 0.15 and 3.03 2 0.25 X lo-”
min-l
, respectively.
By
contrast,
the hPR-B
concentration
had a marked
effect on positive
cooperative
binding
and the dissociation
rate of progesterone.
At high
hPR-B concentrations
(3-5 nM), the limiting
Hill coefficient
was 1.49
2 0.11, which is indicative
ofmoderately
strong positive cooperativity,
whereas
at lower hPR-B concentrations
(l-3 IIM), the Hill coefficient
48201;
Health
and
was reduced
to 1.1, which is essentially
noncooperative.
The [“Hlprogesterone
dissociation
rate was 4.52 i- 0.44 X lo-”
min ’ at the
higher
concentrations
of hPR-B
and was increased
to 1.6 2 0.11
x lo-”
min-’
at the lower concentrations.
Thus, over the same concentration
range
where
hPR-A
exhibited
no significant
change
in
positive
cooperativity
or the dissociation
rate, these progesteronebinding
properties
were highly
dependent
on the concentration
of
hPR-B.
When hPR-A
and hPR-B
were mixed,
positive
cooperative
binding
and the dissociation
rate were more similar
to hPR-B than to
hPR-A,
in that both binding
parameters
were dependent
on the concentration
of receptor.
However,
the hPR-AB
mixture
differed
from
hPR-B alone in that the mixture
required
a greater
receptor
concentration
(7-10
us.. 3-5 nM) to exhibit
positive
cooperativity
and the
increased
dissociation
rate. These results
show, first, that each hPR
isoform
displays
different
[“HIprogesterone-binding
properties,
which
are most prominent
at low concentrations
of receptor,
and
second, that one isoform
can influence
the other. As the two receptor
forms differ only at the N-terminus,
yet positive
cooperativity
and
changes
in the dissociation
rate constant
are indicative
of conformational changes affecting
hormone
binding,
these results also strongly
suggest that the N-terminus
may directly
or indirectly
interact
with
the C-terminal
ligand-binding
domain.
(Endocrinology
137: 23392346, 1996)
T
HE HUMAN
progesterone
receptor (hPR), a ligand-activated transcription
factor, exists in two isoforms, designated A and B (1,2). The only structural difference between
the two forms lies in the additional
164 amino acids present
at the amino-terminal
end of hPR-B that are absent in hPR-A
(3). Recent reports demonstrate
a functional
difference
between the A and B forms. hPR-A can act as a transcriptional
repressor of hPR-B (4). The effect is hormone dependent,
and
cell and promoter
specific. The hPR-A and hPR-B isoforms
also respond differently
to progesterone
antagonists;
antagonist-occupied
hPR-B can activate transcription,
whereas antagonist-occupied
hPR-A cannot (5). Furthermore,
coexpression of hPR-A
can block
transcription
activation
by
antagonist-occupied
hPR-B. There is also evidence that the
two receptor isoforms may influence
transcription
through
independent
mechanisms
(6, 7).
Because of these observed differences in the abilities of the
isoforms to activate transcription,
fluctuations
in the levels of
A and B isoforms
may influence
the cellular response to
progesterone
and its antagonists.
For example, the chicken
oviduct exhibits seasonal variation in the level of A receptors
(8). The decreased levels of A receptors in the winter correlate
with decreased nuclear binding
to chromatin
it7 ZJ~ZKJ
and in
vitro. In murine mammary
tissue, the levels of PR-A and PR-B
forms and its corresponding
messenger RNAs vary according to the developmental
state of the animal: nulliparous,
pregnant,
lactating, or lactational
involution
(9, 10). During
the human menstrual
cycle, the levels of total progesterone
and estrogen receptors are highest during the late proliferative phase and are significantly
lower during the late secretory phase (11). The ratio of the A and B forms in the
uterine endometrium
also changes during the menstrual
cycle (12).
The mechanism
of action of the steroid hormone receptors
includes several steps, starting with ligand binding
and the
associated conformational
changes in the protein, dimeriza-
Received
January
5, 1996.
Address
all correspondence
and requests
for reprints
to: Dr. D. F.
Skafar, Department
of Physiology,
Wayne
State University
School of
Medicine,
540 East Canfield,
Detroit,
Michigan
48201.
E-mail:
.
* This work was supported
by NSF Grants
IBN-9104857
and IBN9407376 (to D.F.S.) and the Wayne
State University
Minority
Faculty
Research Fund (to D.F.S.).
2339
LIGAND-BINDING
2340
PROPERTIES
tion, phosphorylation,
DNA binding,
and interactions
with
other transcription
factors (13, 14). It is important
to determine the step(s) in the mechanism
of action of steroid receptors that differs between the A and B forms to understand
the basis for the observed differences
in transactivation.
In
particular,
as hormone
binding
is the biological
signal, the
question arises whether
hormone
binding
and steps associated with it, such as conformation
changes in the receptor,
are different
between
the two forms. Dimerization
of the
hPR, besides being a fundamental
property
of the protein,
has a potential
role as a regulatory
step. For the hPR, three
distinct dimeric complexes,
composed
of AA, AB, and BB,
occur when complexed
with the progesterone
response element (15, 16) and in solution (15). It is, therefore, critical to
understand
the conditions
under
which
receptors
form
dimers and how dimerization
affects their biochemical
properties and biological
activity.
Studies of the binding
mechanism
and kin (...truncated)